It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Enlarged vestibular aqueduct (EVA) is one of the most commonly identified inner ear malformations in hearing loss patients including Pendred syndrome. While biallelic mutations of the SLC26A4 gene, encoding pendrin, causes non-syndromic hearing loss with EVA or Pendred syndrome, a considerable number of patients appear to carry mono-allelic mutation. This suggests faulty pendrin regulatory machinery results in hearing loss. Here we identify EPHA2 as another causative gene of Pendred syndrome with SLC26A4. EphA2 forms a protein complex with pendrin controlling pendrin localization, which is disrupted in some pathogenic forms of pendrin. Moreover, point mutations leading to amino acid substitution in the EPHA2 gene are identified from patients bearing mono-allelic mutation of SLC26A4. Ephrin-B2 binds to EphA2 triggering internalization with pendrin inducing EphA2 autophosphorylation weakly. The identified EphA2 mutants attenuate ephrin-B2- but not ephrin-A1-induced EphA2 internalization with pendrin. Our results uncover an unexpected role of the Eph/ephrin system in epithelial function.
While biallelic mutations of the SLC26A4 gene cause non-syndromic hearing loss with enlarged vestibular aqueducts or Pendred syndrome, a considerable number of patients carry mono-allelic mutations. Here the authors identify EPHA2 as another causative gene of Pendred syndrome with SLC26A4.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Max Planck Institute for Heart and Lung Research, Laboratory for Cell Polarity and Organogenesis, Bad Nauheim, Germany (GRID:grid.418032.c) (ISNI:0000 0004 0491 220X); Membrane Plasticity in Tissue Development and Remodeling, GRK 2213, Philipps-Universität Marburg, DFG Research Training Group, Marburg, Germany (GRID:grid.10253.35) (ISNI:0000 0004 1936 9756)
2 Shinshu University School of Medicine, Department of Otorhinolaryngology, Matsumoto, Japan (GRID:grid.263518.b) (ISNI:0000 0001 1507 4692)
3 Kyoto University, Institute of Laboratory Animals, Graduate School of Medicine, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)
4 Max Planck Institute for Heart and Lung Research, Laboratory for Cell Polarity and Organogenesis, Bad Nauheim, Germany (GRID:grid.418032.c) (ISNI:0000 0004 0491 220X)
5 Max Planck Institute for Heart and Lung Research, Department of Pharmacology, Bad Nauheim, Germany (GRID:grid.418032.c) (ISNI:0000 0004 0491 220X)
6 Department of Otolaryngology - Head and Neck Surgery Kyoto University Graduate School of Medicine, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)
7 QIMR Berghofer Medical Research Institute, Brisbane, Australia (GRID:grid.1049.c) (ISNI:0000 0001 2294 1395)
8 Yonsei University College of Medicine, Department of Pharmacology, Seoul, Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454)
9 Max Planck Institute for Heart and Lung Research, Department of Cardiac Development and Remodelling, Bad Nauheim, Germany (GRID:grid.418032.c) (ISNI:0000 0004 0491 220X)
10 University of Cologne, Institute for Genetics and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777)
11 MRI and µCT Service Group, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany (GRID:grid.418032.c) (ISNI:0000 0004 0491 220X)
12 Scientific Service Group Biomolecular Mass Spectrometry Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany (GRID:grid.418032.c) (ISNI:0000 0004 0491 220X); German Centre for Cardiovascular Research (DZHK), Partner Site - Rhine-Main, Berlin, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237)
13 Max Planck Institute for Heart and Lung Research, Laboratory for Cell Polarity and Organogenesis, Bad Nauheim, Germany (GRID:grid.418032.c) (ISNI:0000 0004 0491 220X); Membrane Plasticity in Tissue Development and Remodeling, GRK 2213, Philipps-Universität Marburg, DFG Research Training Group, Marburg, Germany (GRID:grid.10253.35) (ISNI:0000 0004 1936 9756); Kumamoto University International Research Center for Medical Scinece, Kumamoto, Japan (GRID:grid.274841.c) (ISNI:0000 0001 0660 6749)